Avivagen Announces CEO Update to Shareholders

Ottawa, ON /Business Wire/ January 26, 2022 /– Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, announces a CEO update to shareholders. To […]

Avivagen Announces Appointment of James Nickerson as President

Ottawa, ON /Business Wire/ January 25, 2022 /– Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is excited to announce the appointment of James  (“Jamie”) Nickerson, […]

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2021

Ottawa, ON /Business Wire/ January 19, 2022 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”) today reported its audited financial results for the year ended October 31, 2021. Unless otherwise noted, all figures are in Canadian currency. The Corporation’s Audited Financial Statements for the year ended October 31, 2021, and the accompanying Management’s Discussion […]

Avivagen Secures Large OxC-betaTM Livestock Order in Asia

3 tonne order represents a 43% increase over most recent shipment to same customer Growth during pandemic signals strong impact on market share through use of OxC-betaTM Ottawa, ON / Business Wire/ October 18, 2021 / –/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion […]

Avivagen to Hold Webcast to Discuss Landmark Deal with AB Vista

AB Vista becomes the exclusive distribution partner for OxC-betaTM for poultry, swine, ruminants (dairy and beef) and aquaculture uses in the United States, Brazil and Thailand Webcast to take place Wednesday, October 6th, 2021, at 10:30 a.m. EST Ottawa, ON /Business Wire/ October 4, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused […]

AB Vista and Avivagen Strike OxC-betaTM Supply Agreement in the United States, Brazil and Thailand

Eight-year agreement expected to increase OxC-BetaTM access and adoption in the largest feed production markets worldwide AB Vista to become exclusive distributor for use with poultry, swine, ruminants and aquaculture in United States, Brazil and Thailand AB Vista and Avivagen to collaborate on development efforts Ottawa, ON/Business Wire/ October 1, 2021/ Leading global animal nutrition […]

Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021

Ottawa, ON /Business Wire/ September 30, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), after releasing its third quarter results yesterday is pleased to provide further detail about product shipments during the third quarter in order to address questions it has received from investors following its earlier press release. The announced 4.4-tonne order for OxC-betaTM Livestock was […]

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2021

• Total of 8 tonnes in orders secured or shipped during the quarter • Quarter represents more than 43% of 2020 fiscal year Ottawa, ON /Business Wire/ September 29, 2021/ Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances […]

Avivagen Announces Strategic Changes to Support Growth in Asia and South America

Addition of Mr. Lesley Nernberg brings technical sales and marketing expertise to Asia expansion efforts Termination of distribution agreement with São Paulo-based Look Chemicals creates opportunity for accelerated adoption of OxC-betaTM Livestock in Brazil Ottawa, ON /Business Wire/ July 22, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing […]

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

AvivagenLogo

Ottawa, ON / Business Wire/ June 11, 2021/ Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, announces that it has received approval by the TSX Venture […]